MF59-eTIV-H5N1 + placebo

MF59-eTIV-H5N1 + placebo is a combination product used in clinical research, consisting of an MF59-adjuvanted H5N1 influenza vaccine and a placebo. The MF59-adjuvanted H5N1 vaccine is a subunit influenza vaccine targeting the avian influenza A (H5N1) virus, formulated with the oil-in-water emulsion adjuvant MF59 to enhance immunogenicity. The adjuvant, composed primarily of squalene oil emulsified in water with surfactants such as polysorbate 80 and sorbitan trioleate, boosts immune responses by promoting chemokine and cytokine production and recruiting immune cells to the injection site[3][4][7]. This formulation has been shown to induce strong humoral immunity and immunologic memory against H5N1 strains in adults[7]. The "placebo" component refers to an inert substance administered for control purposes in clinical trials.